Vandana Singh's Insider Trades & SAST Disclosures
Vandana Singh's most recent trade in Ajanta Pharma Ltd. was a Disposal of 548 Equity Shares done at an average price of Rs. 2722.5 . Disclosure was reported to the exchange on Feb. 28, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for Vandana Singh in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ajanta Pharma | VANDANA SHAILESH SINGH | Designated Person | Disposal | 28 Feb 2025 | 548 | 0 (0%) | 0.00% | 2722.5 | 1,491,903 | 27 Feb 2025 27 Feb 2025 |
Insider Trading | Equity Shares | Market Sale |
| Syngene Intl | Vandana Singh | Other | Acquisition | 24 Sep 2020 | 2,114 | 2,672 (0%) | 0.00% | 558.4 | 1,180,563 | 23 Sep 2020 23 Sep 2020 |
Insider Trading | Equity Shares | ESOP |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.